Heterogeneous genetic alterations in sporadic nephrotic syndrome associate with resistance to immunosuppression

Journal of the American Society of Nephrology

Volumn 26, Issue 1, 2015, Pages 230-236

  Giglio, Sabrina ^a,b   Provenzano, Aldesia ^a   Mazzinghi, Benedetta ^b   Becherucci, Francesca ^b   Giunti, Laura ^b   Sansavini, Giulia ^b   Ravaglia, Fiammetta ^b   Roperto, Rosa Maria ^b   Farsetti, Silvia ^b   Benetti, Elisa ^c   Rotondi, Mario ^d   Murer, Luisa ^c   Lazzeri, Elena ^a   Lasagni, Laura ^a   Materassi, Marco ^b   Romagnani, Paola ^a,b  

^a UNIVERSITY OF FLORENCE   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

^c UNIVERSITY OF PADOVA   (Italy)

^d UNIVERSITY OF PAVIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

PREDNISONE; IMMUNOSUPPRESSIVE AGENT; STEROID;

ADULT; ARTICLE; CHILD; CLINICAL FEATURE; FEMALE; GENE MUTATION; GENETIC VARIABILITY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MAJOR CLINICAL STUDY; MALE; NEPHROTIC SYNDROME; NEXT GENERATION SEQUENCING; ONSET AGE; PHENOTYPE; PRIORITY JOURNAL; ADOLESCENT; ALGORITHM; ALLELE; ANIMAL; BIOLOGICAL MODEL; BIOPSY; GENETICS; HIGH THROUGHPUT SEQUENCING; INFANT; MISSENSE MUTATION; MUTATION; PRESCHOOL CHILD; PROCEDURES; RETROSPECTIVE STUDY;

ADOLESCENT; ALGORITHMS; ALLELES; ANIMALS; BIOPSY; CHILD; CHILD, PRESCHOOL; FEMALE; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; INFANT; MALE; MODELS, GENETIC; MUTATION; MUTATION, MISSENSE; NEPHROTIC SYNDROME; PHENOTYPE; RETROSPECTIVE STUDIES; STEROIDS;

EID: 84924131555     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2013111155     Document Type: Article

References (36)

1. Haraldsson B, Nyström J, Deen WM: Properties of the glomerular barrier and mechanisms of proteinuria. Physiol Rev 88: 451-487, 2008
2. Hildebrandt F: Genetic kidney diseases. Lancet 375: 1287-1295, 2010
3. Benoit G, Machuca E, Antignac C: Hereditary nephrotic syndrome: A systematic approach for genetic testing and a review of associated podocyte gene mutations. Pediatr Nephrol 25: 1621-1632, 2010
4. Wei C, Trachtman H, Li J, Dong C, Friedman AL, Gassman JJ, McMahan JL, Radeva M, Heil KM, Trautmann A, Anarat A, Emre S, Ghiggeri GM, Ozaltin F, Haffner D, Gipson DS, Kaskel F, Fischer DC, Schaefer F, Reiser J; PodoNet and FSGS CT Study Consortia: Circulating suPAR in two cohorts of primary FSGS. J Am Soc Nephrol 23: 2051-2059, 2012
5. Torban E, Bitzan M, Goodyer P: Recurrent focal segmental glomerulosclerosis: A discrete clinical entity. Int JNephrol 2012: 246128, 2012
6. Cravedi P, Kopp JB, Remuzzi G: Recent progress in the pathophysiology and treatment of FSGS recurrence. Am J Transplant 13: 266-274, 2013
7. Tryggvason K, Patrakka J, Wartiovaara J: Hereditary proteinuria syndromes and mechanisms of proteinuria. N Engl J Med 354: 1387-1401, 2006
8. Löwik MM, Groenen PJ, Levtchenko EN, Monnens LA, van den Heuvel LP: Molecular genetic analysis of podocyte genes in focal segmental glomerulosclerosis - a review. Eur J Pediatr 168: 1291-1304, 2009
9. Piscione TD, Licht C: Genetics of proteinuria: An overview of gene mutations associated with nonsyndromic proteinuric glomerulopathies. Adv Chronic Kidney Dis 18: 273-289, 2011
10. Machuca E, Benoit G, Antignac C: Genetics of nephrotic syndrome: Connecting molecular genetics to podocyte physiology. Hum Mol Genet 18[R2]: R185-R194, 2009
11. Saleem MA: New developments in steroid-resistant nephrotic syndrome. Pediatr Nephrol 28: 699-709, 2013
12. McCarthy HJ, Bierzynska A, Wherlock M, Ognjanovic M, Kerecuk L, Hegde S, Feather S, Gilbert RD, Krischock L, Jones C, Sinha MD, Webb NJ, Christian M, Williams MM, Marks S, Koziell A, Welsh GI, Saleem MA; RADAR the UK SRNS Study Group: Simultaneous sequencing of 24 genes associated with steroid-resistant nephrotic syndrome. Clin J Am Soc Nephrol 8: 637-648, 2013
13. Richards CS, Bale S, Bellissimo DB, Das S, Grody WW, Hegde MR, Lyon E, Ward BE; Molecular Subcommittee of the ACMG Laboratory Quality Assurance Committee: ACMG recommendations for standards for interpretation and reporting of sequence variations: Revisions 2007. Genet Med 10: 294-300, 2008
14. Yang Y, Muzny DM, Reid JG, Bainbridge MN, Willis A, Ward PA, Braxton A, Beuten J, Xia F, Niu Z, Hardison M, Person R, Bekheirnia MR, Leduc MS, Kirby A, Pham P, Scull J, Wang M, Ding Y, Plon SE, Lupski JR, Beaudet AL, Gibbs RA, Eng CM: Clinical whole-exome sequencing for the diagnosis of mendelian disorders. N Engl JMed 369: 1502-1511, 2013
15. Jacob HJ: Next-generation sequencing for clinical diagnostics. N Engl J Med 369: 1557-1558, 2013
16. Oleggini R, Bertelli R, Di Donato A, Di Duca M, Caridi G, Sanna-Cherchi S, Scolari F, Murer L, Allegri L, Coppo R, Emma F, Camussi G, Perfumo F, Ghiggeri GM: Rare functional variants of podocin (NPHS2) promoter in patients with nephrotic syndrome. Gene Expr 13: 59-66, 2006
17. Boute N, Gribouval O, Roselli S, Benessy F, Lee H, Fuchshuber A, Dahan K, Gubler MC, Niaudet P, Antignac C: NPHS2, encoding the glomerular protein podocin, ismutated in autosomal recessive steroid-resistant nephrotic syndrome. Nat Genet 24: 349-354, 2000
18. Caridi G, Bertelli R, Carrea A, DiDuca M, Catarsi P, Artero M, Carraro M, Zennaro C, Candiano G, Musante L, Seri M, Ginevri F, Perfumo F, Ghiggeri GM: Prevalence, genetics, and clinical features of patients carrying podocin mutations in steroid-resistant nonfamilial focal segmental glomerulosclerosis. J Am Soc Nephrol 12: 2742-2746, 2001
19. Berdeli A, Mir S, Yavascan O, Serdaroglu E, Bak M, Aksu N, Oner A, Anarat A, Donmez O, Yildiz N, Sever L, Tabel Y, Dusunsel R, Sonmez F, Cakar N: NPHS2 (podicin) mutations in Turkish children with idiopathic nephrotic syndrome. Pediatr Nephrol 22: 2031-2040, 2007
20. Tsukaguchi H, Sudhakar A, Le TC, Nguyen T, Yao J, Schwimmer JA, Schachter AD, Poch E, Abreu PF, Appel GB, Pereira AB, Kalluri R, Pollak MR: NPHS2 mutations in late-onset focal segmental glomerulosclerosis: R229Q is a common disease-associated allele. J Clin Invest 110: 1659-1666, 2002
21. Mao J, Zhang Y, Du L, Dai Y, Yang C, Liang L: Expression profile of nephrin, podocin, and CD2AP in Chinese children with MCNS and IgA nephropathy. Pediatr Nephrol 21: 1666-1675, 2006
22. Sweeney E, Fryer A, Mountford R, Green A, McIntosh I: Nail patella syndrome: A review of the phenotype aided by developmental biology. J Med Genet 40: 153-162, 2003
23. Teer JK, Mullikin JC: Exome sequencing: The sweet spot before whole genomes. Hum Mol Genet 19[R2]: R145-R151, 2010
24. Huber TB, Kwoh C, Wu H, Asanuma K, Gödel M, Hartleben B, Blumer KJ, Miner JH, Mundel P, Shaw AS: Bigenic mouse models of focal segmental glomerulosclerosis involving pairwise interaction of CD2AP, Fyn, and synaptopodin. J Clin Invest 116: 1337-1345, 2006
25. Davin JC, Rutjes NW: Nephrotic syndrome in children: From bench to treatment. Int J Nephrol 2011: 372304, 2011
26. Fogo AB: The spectrumof FSGS: Does pathologymatter? Nephrol Dial Transplant 25: 1034-1036, 2010
27. Laurin LP, Lu M, Mottl AK, Blyth ER, Poulton CJ, Weck KE: Podocyte-associated gene mutation screening in a heterogeneous cohort of patients with sporadic focal segmental glomerulosclerosis [published online ahead of print April 21, 2014]. Nephrol Dial Transplant
28. Malina M, Cinek O, Janda J, Seeman T: Partial remission with cyclosporine A in a patient with nephrotic syndrome due to NPHS2 mutation. Pediatr Nephrol 24: 2051-2053, 2009
29. Hinkes B, Wiggins RC, Gbadegesin R, Vlangos CN, Seelow D, Nürnberg G, Garg P, Verma R, Chaib H, Hoskins BE, Ashraf S, Becker C, Hennies HC, Goyal M, Wharram BL, Schachter AD, Mudumana S, Drummond I, Kerjaschki D, Waldherr R, Dietrich A, Ozaltin F, Bakkaloglu A, Cleper R, Basel-Vanagaite L, Pohl M, Griebel M, Tsygin AN, Soylu A, Müller D, Sorli CS, Bunney TD, Katan M, Liu J, Attanasio M, O 'toole JF, Hasselbacher K, Mucha B, Otto EA, Airik R, Kispert A, Kelley GG, Smrcka AV, Gudermann T, Holzman LB, Nürnberg P, Hildebrandt F: Positional cloning uncovers mutations in PLCE1 responsible for a nephrotic syndrome variant that may be reversible. Nat Genet 38: 1397-1405, 2006
30. Plank C, Kalb V, Hinkes B, Hildebrandt F, Gefeller O, Rascher W; Arbeitsgemeinschaft für Pädiatrische Nephrologie: Cyclosporin A is superior to cyclophosphamide in children with steroid-resistant nephrotic syndrome-a randomized controlled multicentre trial by the Arbeitsgemeinschaft für Pädiatrische Nephrologie. Pediatr Nephrol 23: 1483-1493, 2008
31. Ruf RG, Lichtenberger A, Karle SM, Haas JP, Anacleto FE, Schultheiss M, Zalewski I, Imm A, Ruf EM, Mucha B, Bagga A, Neuhaus T, Fuchshuber A, Bakkaloglu A, Hildebrandt F; Arbeitsgemeinschaft Für Pädiatrische Nephrologie Study Group: Patients with mutations in NPHS2 (podocin) do not respond to standard steroid treatment of nephrotic syndrome. J Am Soc Nephrol 15: 722-732, 2004
32. Gellermann J, Stefanidis CJ, Mitsioni A, Querfeld U: Successful treatment of steroid-resistant nephrotic syndrome associated with WT1 mutations. Pediatr Nephrol 25: 1285-1289, 2010
33. Büscher AK, Kranz B, Büscher R, Hildebrandt F, Dworniczak B, Pennekamp P, Kuwertz-Bröking E, Wingen AM, John U, Kemper M, Monnens L, Hoyer PF, Weber S, Konrad M: Immunosuppression and renal outcome in congenital and pediatric steroid-resistant nephrotic syndrome. Clin J Am Soc Nephrol 5: 2075-2084, 2010
34. Kidney Disease: Improving Global Outcomes (KDIGO) Glomerulonephritis Work Group. KDIGO Clinical Practice Guideline for Glomerulonephritis. Kidney Int Suppl 2: S139-S174, 2012
35. Bell CJ, Dinwiddie DL, Miller NA, Hateley SL, Ganusova EE, Mudge J, Langley RJ, Zhang L, Lee CC, Schilkey FD, Sheth V, Woodward JE, Peckham HE, Schroth GP, Kim RW, Kingsmore SF: Carrier testing for severe childhood recessive diseases by next-generation sequencing. Sci Transl Med 3: ra4, 2011
36. Angelotti ML, Ronconi E, Ballerini L, Peir0ed A, Mazzinghi B, Sagrinati C, Parente E, Gacci M, Carini M, Rotondi M, Fogo AB, Lazzeri E, Lasagni L, Romagnani P: Characterization of renal progenitors committed toward tubular lineage and their regenerative potential in renal tubular injury. Stem Cells 30: 1714-1725, 2012